SELLAS Life Sciences Group, Inc. - COM NEW (SLS)

Historical Portfolio Holders from Q4 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
4.06M
Holdings value Q2 2024
$4.83M
Value change Q2 2024
-$3.47M
Grand Portfolio weight change Q2 2024
0%
Number of holders
28
Number of buys Q2 2024
20
Number of sells Q2 2024
-10
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 4.06M $4.83M -$3.47M $1.19 32
2024 Q1 7.72M $7.79M +$4.21M $1.01 29
2023 Q4 3.49M $3.7M +$353K $1.06 32
2023 Q3 2.75M $4.51M -$594K $1.64 26
2023 Q2 3.11M $4.89M +$175K $1.57 22
2023 Q1 3M $4.28M +$1.44M $1.43 22
2022 Q4 1.89M $4.46M +$91.3K $2.36 28
2022 Q3 2.19M $4.42M -$1.74M $2.02 26
2022 Q2 2.98M $6.64M +$1.67M $2.23 24
2022 Q1 1.69M $11.3M -$279K $6.68 25
2021 Q4 1.73M $9.59M -$1.34M $5.53 27
2021 Q3 1.86M $17.1M -$844K $9.16 29
2021 Q2 1.9M $21.3M +$4.74M $11.10 30
2021 Q1 1.55M $13.2M +$5.29M $8.54 28
2020 Q4 925K $5.37M +$2.5M $5.81 19
2020 Q3 617K $1.63M +$397K $2.65 10
2020 Q2 456K $1.34M +$145K $2.93 12
2020 Q1 416K $720K -$87.8K $1.74 10
2019 Q4 389K $1.67M +$1.67M $4.30 10